PT-141 (Bremelanotide)

PT-141 (Bremelanotide) is a peptide therapy used to treat erectile dysfunction (ED) in men and hypoactive sexual desire disorder (HSDD) in women. Originally developed as a sunless tanning agent, PT-141 is a melanocyte-stimulating hormone (MSH) that enhances sexual arousal by activating neurons in the hypothalamus, increasing libido and improving sexual satisfaction. Unlike PDE5 inhibitors, PT-141 acts on the nervous system rather than the vascular system.

Key Benefits:

• Improves low libido in men and women
• Enhances sexual satisfaction and well-being
• Treats erectile dysfunction (ED)
• Supports treatment of HSDD in women
• Promotes skin pigmentation as a sunless tanning agent
• Increases energy levels
• Provides sense of wellbeing